Sunday 11 October 2026 Export all HCSG data to Excel Powerpack

Healthcare Services Group, Inc.

Healthcare Services Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.8 billion, up 7.08% from fiscal 2024. In the quarter to June 2026, revenue grew 2.69%, EPS grew 175.0% and free cash flow fell 26.0%, each against the same quarter a year earlier. Dividend growth for ten consecutive years.

20.59 0.07 −0.34%

Follow HCSG

Alert me

Market cap: $1.4B
P/E: 11.9×
Fwd P/E: 19.2×
Dividend yield: —
F-score: 8/9
Altman Z: 6.55
Beneish M: −3.09
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Insider Decisions trades per month

Total sells 3.38

Totals in millions of $.

	Dec 25			Mar 26			Jun 26			Sep 26
Buy	—	—	—	—	—	—	—	—	—	—	—	—
Sell	—	—	—	4	—	—	—	—	—	1	—	—

Insider Ownership 1.42%

Capital & Financial Ratios $m

Market Cap 1,420.00

Revenue 1,864.59

Net Income 122.95

Free Cash Flow 148.71

Net Debt (200.86)

Current Ratio 3.02

Debt/Equity 0.00

P/E ratio 11.92

Fwd P/E 19.20

P/S ratio 0.76

P/B ratio 2.73

Past 5Y EPS Growth (9.31%)

This Y EPS Growth 8.50%

Next Y EPS Growth 1.81%

Next Y revenue growth 4.56%

Next 5Y EPS Growth 8.98%

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

EV/Sales, ten years

P/E against its own 10 years 0.11%

10-year low 10-year high

P/S against its own 10 years 34.90%

10-year low 10-year high

P/B against its own 10 years 34.49%

10-year low 10-year high

EV/Sales against its own 10 years 35.49%

10-year low 10-year high

EV/FCF against its own 10 years 5.20%

10-year low 10-year high

Dividends

Payout Ratio —

Annual Dividend Rate —

Annual Dividend Yield —

	total	individual payouts
2024	Powerpack
2023	Powerpack
2022	0.85	0.21 0.21 0.21 0.22
2021	0.83	0.21 0.21 0.21 0.21
2020	0.81	0.20 0.20 0.20 0.21
2019	0.79	0.20 0.20 0.20 0.20
2018	0.77	0.19 0.19 0.19 0.20
2017	0.75	0.19 0.19 0.19 0.19
2016	0.73	0.18 0.18 0.18 0.19

special payouts not included in total or ratios

Assets vs Liabilities $m

	2023	2024	2025	Q'26
Cash	147	136	204	201
Receivables	384	382	335	324
Inventory	18	17	17	16
Other	—	—	—	—
	572	557	576	569

	2023	2024	2025	Q'26
Payables	83	81	77	86
ST’ Debt	25	—	—	—
Other	—	—	—	—
	217	193	170	188

Compound Annual Growth %

	10y	5y	3y
Sales	2.49%	0.86%	2.82%
Cash Flow	8.63%	(7.77%)	0.00%
Earnings	0.18%	(9.76%)	19.92%
Book Value	5.58%	1.21%	6.85%

Revenue $m

	Mar	Jun	Sep	Dec	Year
’26	463	471	—	—	—
’25	448	458	464	467	1,837
’24	423	426	428	438	1,716
’23	417	419	411	424	1,671
’22	427	425	414	424	1,690
’21	408	398	416	420	1,642
’20	449	452	436	423	1,760

Fiscal quarters ending in the months shown.

Operating Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	44	22	—	—	—
’25	28	29	71	17	145
’24	(26)	16	4	36	31
’23	(16)	7	3	49	43
’22	(30)	9	(10)	23	(8)
’21	4	25	(23)	31	37
’20	13	80	49	76	217

Fiscal quarters ending in the months shown.

Free Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	42	20	—	—	—
’25	26	27	70	16	139
’24	(28)	15	3	35	25
’23	(17)	6	1	48	38
’22	(31)	8	(11)	22	(13)
’21	3	24	(25)	30	32
’20	12	79	48	74	213

Fiscal quarters ending in the months shown.

EPS $

	Mar	Jun	Sep	Dec	Year
’26	0.37	0.32	—	—	—
’25	0.23	(0.44)	0.59	0.44	0.81
’24	0.21	(0.02)	0.19	0.16	0.53
’23	0.17	0.12	(0.07)	0.31	0.52
’22	0.15	0.09	0.00	0.22	0.47
’21	0.33	0.13	0.13	0.07	0.61
’20	0.27	0.31	0.37	0.37	1.32

Fiscal quarters ending in the months shown.

Group	Line	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026e
Price, $
Price, $	Low	31.50	37.54	35.04	21.16	15.80	16.25	11.55	8.75	8.98	9.13	Analyst estimates 2026–2028 Powerpack
	High	42.18	55.68	56.20	44.76	31.30	35.80	20.54	15.97	13.00	20.26
People
People	Employees	48,900	55,000	55,000	51,000	44,200	39,200	35,700	33,400	35,300	36,000
	Revenue/emp, $m	0.03	0.03	0.04	0.04	0.04	0.04	0.05	0.05	0.05	0.05
Income, $m
Income, $m	Revenue	1,563	1,861	2,003	1,841	1,760	1,642	1,690	1,671	1,716	1,837
	Gross margin, %	14.28	13.47	11.71	12.38	15.22	14.04	11.44	12.85	13.29	13.03
	EBT	120	133	100	85	129	66	45	53	53	68
	EBT margin, %	7.70	7.14	4.99	4.62	7.34	3.99	2.64	3.17	3.09	3.69
	Net income	77	88	84	65	99	49	34	38	39	59
	Depreciation	9	10	11	15	16	17	18	16	16	17
Per share, $
Per share, $	Revenue	21.48	25.37	27.06	24.75	23.57	21.95	22.74	22.50	23.26	25.38
	Earnings	1.06	1.20	1.13	0.87	1.32	0.61	0.47	0.52	0.54	0.82
	Cash flow	0.57	0.10	1.08	1.26	2.91	0.50	(0.11)	0.59	0.42	2.00
	Capex	(0.07)	(0.07)	(0.06)	(0.06)	(0.05)	(0.07)	(0.06)	(0.07)	(0.08)	(0.08)
	Free cash flow	0.50	0.04	1.02	1.20	2.85	0.42	(0.17)	0.51	0.33	1.92
	Book value	4.66	5.45	5.96	6.19	6.43	6.05	5.63	6.15	6.78	7.05
	Shares, m	73	73	74	74	75	75	74	74	74	72
Valuation, ×
Valuation, ×	P/E	36.09	42.99	35.53	28.28	21.29	27.15	26.92	20.08	21.52	23.32
	P/S	1.80	2.03	1.48	0.98	1.19	0.81	0.55	0.47	0.50	0.75
	P/B	8.29	9.46	6.75	3.93	4.37	2.94	2.22	1.73	1.71	2.71
	EV/Sales	1.74	2.01	1.45	0.92	1.05	0.70	0.49	0.40	0.44	0.66
	EV/FCF	75.02	1,453.52	38.31	19.02	8.63	36.43	(64.13)	17.48	30.24	8.65
Cash, $m
Cash, $m	Operating cash flow	41	8	80	94	217	37	(8)	43	31	145
	Capex	(5)	(5)	(4)	(4)	(4)	(5)	(5)	(5)	(6)	(6)
	Free cash flow	36	3	76	89	213	32	(13)	38	25	139
Balance, $m
Balance, $m	Working capital	314	343	345	367	410	355	320	355	364	406
	Total debt	—	35	30	10	5	7	25	25	—	—
	Net debt	(92)	(47)	(72)	(108)	(259)	(179)	(96)	(122)	(136)	(204)
	Shareholders’ equity	339	400	441	460	480	453	418	457	500	510
Returns, %
Returns, %	ROA	15.34	14.65	12.21	9.13	13.09	6.21	4.57	5.08	4.95	7.40
	ROIC	29.76	21.96	16.60	13.82	33.08	13.11	10.29	8.97	7.73	9.90
	ROE	24.37	23.88	19.87	14.33	20.98	10.40	7.86	8.77	8.25	11.69

Negative figures in brackets.

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

Charts ten years each

Company	Market cap	P/E	Fwd P/E	Revenue growth (Q)	EPS growth (Q)	FCF growth (Q)	Gross margin (Q)	EBIT margin (Q)	Compare
CMPS COMPASS Pathways PLC Sponsored ADR	$1.6B	— (loss-making)	—	—	n/m	−4.18% (below 0%: shrinking)	—	0.00%	Compare
ARDT Ardent Health, Inc.	$1.6B	20.5×	7.7×	−1.40% (below 0%: shrinking)	−76.92% (below 0%: shrinking)	+121.70% (above 0%: growing)	100.00%	3.44%	Compare
HCSG Healthcare Services Group, Inc.	$1.4B	11.9×	19.2×	+2.69% (above 0%: growing)	n/m	−26.02% (below 0%: shrinking)	15.89%	4.72%
AGL Agilon Health, Inc.	$1.4B	— (loss-making)	— (loss-making)	+7.15% (above 0%: growing)	n/m	−50.19% (below 0%: shrinking)	7.17%	0.79%	Compare
PNTG The Pennant Group, Inc.	$1.4B	42.3×	26.9×	+35.76% (above 0%: growing)	+23.81% (above 0%: growing)	−50.94% (below 0%: shrinking)	14.07%	5.77%	Compare
NUTX Nutex Health Inc.	$1.4B	7.9×	6.3×	−13.62% (below 0%: shrinking)	n/m	+19.44% (above 0%: growing)	67.04%	57.75%	Compare
AMN AMN Healthcare Services Inc	$1.4B	13.5×	31.2×	+2.29% (above 0%: growing)	n/m	−389.43% (below 0%: shrinking)	30.58%	4.00%	Compare
USPH U.S. Physical Therapy, Inc.	$1.3B	498×	27.7×	+8.47% (above 0%: growing)	−56.90% (below 0%: shrinking)	−8.24% (below 0%: shrinking)	19.59%	10.25%	Compare
INNV InnovAge Holding Corp.	$1.2B	— (loss-making)	17.2×	+18.31% (above 0%: growing)	n/m	+85.44% (above 0%: growing)	23.88%	3.87%	Compare
Median of peers	$1.4B	20.5×	22.0×	+7.15%	−56.90%	−6.21%	23.88%	3.93%

All 55 Medical Care Facilities stocks →

Healthcare Services Group, Inc. (HCSG) key facts

Strength: Healthcare Services Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.8 billion, up 7.08% from fiscal 2024.
Healthcare Services Group, Inc. (HCSG) is a Medical Care Facilities company in the Healthcare sector, listed on Nasdaq.
As of October 9, 2026, HCSG traded at $20.59, a market capitalization of $1.4 billion.
Return on equity was 11.7% and debt-to-equity 0.00.
Its Piotroski F-score is 8 out of 9 and its Altman Z-score is 6.55 (safe zone) for fiscal 2025.

Source: company filings (standardised) and stockrow calculations.